The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Authors:
- Søren Bang NielsenSNSøren Bang Nielsen
- Alexander K. BuellAlexander K. Buell
- Jørn Døvling KaspersenJKJørn Døvling Kaspersen
- Brian Stougaard VadBVBrian Stougaard Vad
- Wojciech PaslawskiWPWojciech Paslawski
- Gunna ChristiansenGCGunna Christiansen
- Zuzana Valnickova-HansenZVZuzana Valnickova-Hansen
- Maria AndreasenMAMaria Andreasen
- Jan J. EnghildJEJan J. Enghild
- Jan Skov PedersenJan Skov Pedersen
- 16 February 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 136 (10) , 3859-3868
Abstract
Studies of proteins’ formation of amyloid fibrils have revealed that potentially cytotoxic oligomers frequently accumulate during fibril formation. An important question in the context of mechanistic studies of this process is whether or not oligomers are intermediates in the process of amyloid fibril formation, either as precursors of fibrils or as species involved in the fibril elongation process or instead if they are associated with an aggregation process that is distinct from that generating mature fibrils. Here we describe and characterize in detail two well-defined oligomeric species formed by the protein α-synuclein (αSN), whose aggregation is strongly implicated in the development of Parkinson’s disease (PD). The two types of oligomers are both formed under conditions where amyloid fibril formation is observed but differ in molecular weight by an order of magnitude. Both possess a degree of β-sheet structure that is intermediate between that of the disordered monomer and the fully structured amyloid fibrils, and both have the capacity to permeabilize vesicles in vitro. The smaller oligomers, estimated to contain ∼30 monomers, are more numerous under the conditions used here than the larger ones, and small-angle X-ray scattering data suggest that they are ellipsoidal with a high degree of flexibility at the interface with solvent. This oligomer population is unable to elongate fibrils and indeed results in an inhibition of the kinetics of amyloid formation in a concentration-dependent manner.Keywords
Funding Information
- Michael J. Fox Foundation for Parkinson's Research (NA)
- European Molecular Biology Organization (NA)
- Biotechnology and Biological Sciences Research Council (NA)
- Magdalene College, University of Cambridge (NA)
This publication has 80 references indexed in Scilit:
- Fibrillar α-Synuclein and Huntingtin Exon 1 Assemblies Are Toxic to the CellsBiophysical Journal, 2012
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-SynucleinCell, 2012
- Role of Elongation and Secondary Pathways in S6 Amyloid Fibril GrowthBiophysical Journal, 2012
- Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's diseaseNature Chemistry, 2009
- Amyloid Protofibrils of Lysozyme Nucleate and Grow Via Oligomer FusionBiophysical Journal, 2009
- Protein folding and misfoldingNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001